Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022

CONCLUSIONS: Our study of the long-term serological course of SARS-CoV-2 in a nursing home showed that the first SARS-CoV-2 booster vaccine was essential for maintaining antiviral antibody levels. Hybrid immunity sustained SARS-CoV-2 immunity at the highest level. In critical settings such as nursing homes, monitoring the SARS-CoV-2 immune status may guide booster vaccinations.PMID:38579325 | DOI:10.57187/s.3502

Source: Swiss Medical Weekly - April 5, 2024 Category: General Medicine Authors: Lisa Perrig Irene A Abela Nicolas Banholzer Annette Audig é Selina Epp Catrina Mugglin Kathrin Z ürcher Matthias Egger Alexandra Trkola Lukas Fenner Source Type: research